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Background: Non-therapeutic trials in which terminally ill cancer patients are asked to undergo procedures such as
biopsies or venipunctures for research purposes, have become increasingly important to learn more about how
cancer cells work and to realize the full potential of clinical research. Considering that implementing
non-therapeutic studies is not likely to result in direct benefits for the patient, some authors are concerned that
involving patients in such research may be exploitive of vulnerable patients and should not occur at all, or should
be greatly restricted, while some proponents doubt whether such restrictions are appropriate. Our objective was to
explore clinician-researcher attitudes and concerns when recruiting patients who are in advanced stages of cancer
into non-therapeutic research.
Methods: We conducted a qualitative exploratory study by carrying out open-ended interviews with health
professionals, including physicians, research nurses, and study coordinators. Interviews were audio-recorded and
transcribed. Analysis was carried out using grounded theory.
Results: The analysis of the interviews unveiled three prominent themes: 1) ethical considerations; 2) patient-centered
issues; 3) health professional issues. Respondents identified ethical issues surrounding autonomy, respect for persons,
beneficence, non-maleficence, discrimination, and confidentiality; bringing to light that patients contribute to science
because of a sense of altruism and that they want reassurance before consenting. Several patient-centered and health
professional issues are having an impact on the recruitment of patients for non-therapeutic research. Facilitators were
most commonly associated with patient-centered issues enhancing communication, whereas barriers in non-therapeutic
research were most often professionally based, including the doctor-patient relationship, time constraints, and a lack of
education and training in research.
Conclusions: This paper aims to contribute to debates on the overall challenges of recruiting patients to non-therapeutic
research. This exploratory study identified general awareness of key ethical issues, as well as key facilitators and barriers to
the recruitment of patients to non-therapeutic studies. Due to the important role played by clinicians and
clinician-researchers in the recruitment of patients, it is essential to facilitate a greater understanding of the challenges
faced; to promote effective communication; and to encourage educational research training programs.
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Non-therapeutic trials in which terminally ill cancer
patients are asked to undergo procedures such as biop-
sies or venipunctures for research purposes, have be-
come increasingly important to learn more about how
cancer cells work and to realize the full potential of clin-
ical research. Considering the increased use of specimen
collection in clinical trials within the context of emer-
ging ‘personalized’ medicine, one ethical issue looming
over the research community concerns whether cancer
patients should be recruited to non-therapeutic oncology
research [1]. These studies may involve patients who are
in advanced stages of their disease, whose life expectan-
cies are limited [2], and for whom research raises dis-
tinct ethical, as well as logistical challenges. For this type
of research the use of oncology patients is necessary, be-
cause healthy participants cannot offer access to tumor
cells.
Considering that implementing non-therapeutic stud-
ies is not likely to result in direct benefits for the patient,
some authors are concerned that involving patients in
such research may be exploitive of vulnerable patients
and should not occur at all, or should be greatly
restricted [3]. Alternatively, some proponents doubt
whether such restrictions are appropriate [3]. These pro-
ponents view the terminally ill as autonomous indivi-
duals, able to engage in decision-making; thus any
restrictions to this kind of research are seen as paternal-
istic and a form of devaluing their personal autonomy
and self-determination [4]. Although research ethics
boards (REBs) are essential for the general oversight of
human subject research, this ambivalence about whether
the risks of exploitation or harm are important enough
to limit such research has been a source of debate at the
ethics review committee level [3]. Discussions about
recruiting patients to non-therapeutic research have
been questioned for a variety of ethical reasons, includ-
ing: i) increased vulnerability; ii) reconciling researcher
and clinician roles; and iii) familial considerations.
Increased vulnerability
Patients in advanced stages of cancer, who are within
days, weeks or months of dying are the target population
for non-therapeutic oncology studies. They often experi-
ence severe physical and psychological problems [5].
These patients are considered highly vulnerable because
they are very ill, have decreased cognitive abilities, have
severe pain, nausea, anxiety, or have difficulty accepting
their approaching death. Moreover, their physiological
state can change rapidly, such that one day they are fine
and the next day they are preoccupied by something
else. As a result, patients’ motivation to participate may
fluctuate. For example, at times, they may be motivated
to participate for altruistic reasons and for the benefit ofother cancer patients, while at other times, they may
wish to spend their restricted and valuable time with
their families [3].
Reconciling researcher and clinician roles
Clinician-researchers who provide patient care find it
challenging to balance their clinical and researcher roles
[6]. For example, the need to act in the patient’s best
interest (beneficence) and the risk of infection, causing
pain, or other complications as a result of obtaining a bi-
opsy for research raises concerns. Moreover, since
human biological samples are important sources of
DNA, this may also raise concerns about confidentiality
and insurance discrimination [7-9] or give rise to a
unique set of medical-ethical dilemmas about informing
other family members of pertinent findings [10,11].
The clinician-researcher may also be confounded by
issues arising from the therapeutic misconception. Des-
pite clear information on the lack of personal benefit,
patients may still feel that the research could offer a
promising treatment. They may have unrealistic expecta-
tions or see it as an individualized treatment plan
recommended by their doctor [12].
In addition, clinicians may have ethical conflicts stem-
ming from the limited understanding of their role in re-
search. They may also be reluctant to approach their
patients about the prospect of participation because of
their relationship with them, potentially competing loy-
alties, and a wish to consider the wellbeing of the patient
first [6].
Familial considerations
Families often believe terminally ill patients are less
likely to want to participate or to tolerate additional
stress or pain [13,14]. There may be times where the
family will object or become over-protective.
Effective communication between physicians and
patients and their families is essential to high quality
cancer care and constitutes one of the greatest chal-
lenges faced by physicians [15,16]. It requires physicians
to become sensitive to their patient’s emotions and to
demonstrate patience, understanding, empathy, and sup-
port [16,17]. Patients’ needs vary throughout the course
of their disease and with that, so does their need to be
kept informed [18]. As a result, different approaches
need to be taken to adapt and to help them cope [18,19].
In short, how health professionals approach patients
for participation in non-therapeutic research is a sensi-
tive and important issue. It requires a better understand-
ing of the issues to ensure that both science and the
patient’s needs are served. While there are numerous
ethical and social issues surrounding participation in re-
search at the end of life, there is less of an understanding
of how clinicians and researchers address these
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cians may play a key role in informing their cancer
patients about this type of research while being sensitive
to patient needs and wishes.
Acknowledging the complexity of the issue, we con-
ducted a qualitative exploratory study to assess clinician-
researchers’ attitudes when recruiting patients in
advanced stages of cancer into non-therapeutic research.
Non-therapeutic research is defined as research not hav-
ing “direct benefits for participants but [that] may have
future benefits for others” [20]. Advanced stages of can-
cer refers to those who are in Stage III (“Higher num-
bers indicate more extensive disease: Larger tumor size
and/or spread of the cancer beyond the organ in which
it first developed to nearby lymph nodes and/or organs
adjacent to the location of the primary tumor”) or Stage
IV (“The cancer has spread to another organ(s)”) of their
cancer [21].
For the purpose of this paper, the term “respondents”
refers to the seven interviewees (i.e. participants in this
qualitative study), whereas the term “patients” refers to
those individuals who would take part in non-




Respondents were recruited to ensure a variability of
experiences (e.g. gender, age, speciality) and included a
total of seven health professionals: three physicians, two
research nurses, and two study coordinators, all of
whom are involved in oncology research. We used a
combination of purposeful and convenience sampling by
asking the clinical research team and respondents to
suggest other individuals (snowballing), by advertising
on the GEOQ (Groupe d’étude en oncologie du Québec)
website, and through direct contact with researchers of
the Q-CROC Consortium (Québec – Clinical Research
Organization in Cancer), a consortium bringing together
researchers and clinicians throughout Quebec, including
hospitals and research centers. We chose a qualitative
method because it allows for exploring processes that
lead to a better understanding of the different reasons
for including or not including patients in non-
therapeutic research. Ethics approval was obtained from
the McGill University Institutional Review Board.
Data collection
Information was collected between 2010 and 2011 using
open-ended interviews at the time and location of the
respondent’s choice. The interview method was chosen
because it is more flexible and adjustable to the availabil-
ity of the health professionals. The goal was to gain
insight into the perceptions of healthcare providersregarding patient recruitment and participation in non-
therapeutic research. This study was limited to exploring
the issues involving the recruitment of an adult popula-
tion; thus excluding terminally ill minors. The interview
questions and guide were developed on the basis of a re-
view of the literature.
Sample Interview questions
Attitudes and knowledge of research
What do you think about having your patient
participate in a research protocol?
What do you think the physician’s role is? The
researcher’s role?
Have you ever referred patients to a research project?
Have you ever declined referral of patients to a
research project?
Barriers and facilitators to involving patients in
research
What do you think about research that has no obvious
therapeutic benefit?
Should any patient be asked to participate in research
without therapeutic benefit?
Are there barriers that may contribute to your decision
to refer a patient or not?
Are there benefits to participating in research with no
obvious therapeutic benefits?
Who should be involved in the consent? How should
consent be obtained?
What types of information do you or would you
provide to patients?
Should all physicians be asked to participate in research
recruitment?
What factors lead to encouraging or discouraging
patient participation?
Tools for integrating research practice
What tools could you use to address the introduction
of research protocols in your clinic? (Probes: policy
statement, incentives, educational, etc.)
Pilot testing of the questionnaire was carried out by
the multidisciplinary research team. Interviews lasted
45–60 minutes and were performed by an experienced
researcher (DA), in the company of another researcher
(LB).
Data analysis
Interviews were audio-recorded and transcribed, and
responses to open-ended questions were coded by two
individuals (EK and DA). They were analyzed using a
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to identify themes that emerge across the interviews
[22]. A predetermined set of codes was developed from
the interview guide and the relevant literature; however,
new codes were also allowed to emerge from the data.
The data were iteratively coded using NVivo, a soft-
ware for qualitative research and analysis (EK). Then, a
second individual (DA) also coded a subset of the data
for themes. Information was categorized according to
themes. We then took the many codes and through con-
sensus merged them into a handful of themes. Each was
subsequently classified by an overall enhance or deter
factor. The findings are presented with quotes to illus-
trate the themes that emerged. A model was developed
to describe the relationship between the key themes and
a range of points to consider (see Figure 1).
Results
Our analysis of the data reveals three prominent themes:
1) ethical considerations; 2) patient-centered issues; and
3) health professional issues. The results are presentedFigure 1 “Points to consider” to facilitate understanding.under these three themes. Table 1 contains an overview
of the issues.
I) Ethical considerations
There was consensus that certain core ethical principles
should be observed when interacting with patients and
their families. When invited to describe their under-
standing of ethics in the context of non-therapeutic re-
search most respondents articulated the need for:
Autonomy
A primary ethical principle is that participation in any
kind of research requires a free choice (voluntariness)
and appropriate information about the research as well
as the time to better understand the information being
presented to them before consenting. To that end, a po-
tential research participant must be eligible and capable
of providing a voluntary and informed consent.
“[. . .] the patient will never sign the first [day], even
though we explain it to them, they will say I’m going
Table 1 Prominent themes
I. Ethical considerations with respect to non-therapeutic research
• Autonomy
• Respect for persons
• Beneficence
• Non-maleficence






• Communication • Negative research culture
• Informed consent is a continuous
process
• Vulnerability of patient
• Differing opinions
• Research nurse • Psychosocial issues
• Individual contact
• Timing
• Family dynamics and social support
II. Health professional issues
Facilitators Barriers
• Doctor-patient relationship • Doctor-patient
relationship
• Teamwork • Distinction between care
and research
• Time constraints
• Conflict of interest
• Lack of awareness
• Education and training
• Research ethics boards
(REB)
• Funds
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and you come back to see me next week. That’s the
way we proceed, because we want them to collaborate,
we want them to understand [. . .]” (Interviewee 3)
Respect for persons
Respondents recognize that because the patients have
suffered a lot, and perhaps want to be left alone, their
interests and welfare must always take precedence over
the interests of science and society. As a matter of re-
spect for human dignity and to avoid treating people as
a means to an end, physicians must consider the patient
as a human being and demonstrate sensitivity and em-
pathy to his or her needs and emotions.
Many respondents stated that given the sensitive nature
of the recruitment, it is also important to listen to thepatient and to understand his or her personal situation,
because they noted the physician has an ethical and legal
duty to promote the best interests of the patient while
knowing that the investigation can be stressful, particu-
larly if there are no immediate benefits. In such a sce-
nario, it is appropriate to take into consideration the best
interest of the individual.
“[. . .] we have to choose, we have to really be rational
and look at [. . .] the patient as [a] human being, not
as [. . .a] case number – it’s a human being.”
(Interviewee 5)
“Physicians really feel that [. . .in their] relationship
[. . .with their patient,] they have to do what’s best for
their patient and it’s their judgment that has to decide
that.” (Interviewee 7)Beneficence
When asked to describe the positive aspects of this type
of research, some respondents suggested that as a result
of participating in research, patients may receive better
care because it provides them with the opportunity to be
treated by specialists and to be closely monitored. In
fact, as the following text expresses, if they participate in
research, they may benefit because:
“There’s just more hands involved and the scheduling
is fixed. So a scan is done. It’s done according to when
it should be done. And so [. . .] I think that’s a fringe
benefit. I think there are all these psycho-spiritual
benefits that are real and true.” (Interviewee 1)Non-maleficence
With non-therapeutic research involving biopsies, for
example, many respondents highlighted the potential to
cause distress for the participant, especially because
there is no anticipated physical benefit and greater than
minimal risk. When assessing risk, respondents felt it
was important to address the risks that may be significant
(i.e. increased pain or side effects), prior to participation
in research.
“they were already worried about the procedure [. . .]
because they didn’t want their father to have pain or
discomfort or [. . .] risk[s] simply for [. . .] research
purposes.” (Interviewee 2)
Moreover, some recognized that patients are emotion-
ally drained and overwhelmed. As a result, there is an
ethical obligation to be cautious about causing distress
and to make them feel like partners during the recruit-
ment process.
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and [. . .] it’s for us to say, okay, look, let’s talk about
this tomorrow. Today, you [. . .] digest what you’re
facing. I wish you didn’t have to face this but you do.
And we’ll talk about the implications tomorrow. It’s a
process”. (Interviewee 1)
Furthermore, some health professionals recognized
that genetic information that may arise from genomic
research may be a source of discrimination. Examples of
discrimination included denial of insurability and em-
ployability, for the patient as well as for his or her family.
“Something that can allow a family to be targeted and
identified then I think this would [. . .be] an element
that would [. . .] turn away people from the study
because they don’t want the stigma for themselves but
also they don’t want a stigma for their families.”
(Interviewee 4)
“[insurability] or employability. Those are elements
that you know eventually might be detrimental for the
whole [. . .] quality of life [. . .] of not only the patient
but the others around them.” (Interviewee 4)Public good
Many respondents mentioned that the benefits of non-
therapeutic research include better knowledge and more
insight into the disease rather than individual benefits
for the patients. They also mentioned that participation
in non-therapeutic research was an altruistic gesture that
contributes to the greater good. According to respon-
dents, participation is a way of directly helping their
families to avoid a similar situation and to improve the
health of future generations.
“For cancer patients that have more advanced [stages
of a] disease, there [. . .are] other elements that are
important to the patient that ha[ve] to do with their
mortality and contributing. There’s some kind of
altruism that evolves, contributing to the greater good
and to the benefit of others.” (Interviewee 1)
Some also stated that patients are sometimes more
than happy to encourage researchers to use these bio-
logical samples to help someone else and for future
medical advancements.II) Patient-centered issues
Several patient-centered issues have an impact on the re-
cruitment of patients for non-therapeutic research. Some
issues facilitate the process and others are described as
barriers.Communication
Fostering open, clear and accurate communication with
patients during the recruitment process is seen as essen-
tial. Specifically, communication can facilitate recruit-
ment by ensuring that the patient will understand every
step of the research process, that their questions will be
addressed, and that they will receive sufficient support.
Negative research culture
Many respondents mentioned that there is much errone-
ous information about clinical trials in the public do-
main. Some highlighted the concern that patients may
perceive themselves as guinea pigs when participating in
non-therapeutic research, perhaps as a result of misin-
formation over the years.
“I’d say five years ago, a very strong sense of [. . .]
guinea pigs [existed], and there was a lot of
misinformation about clinical trials.” (Interviewee 1)
A compelling counter argument is to ensure that the
patients receive reliable information and understand the
real goal of the research. Another approach is to host
conferences and discussion groups with patients and
participants to enhance the exchange of experiences and
information about research and the research sites. One
effect may be to reduce the fear of being a guinea pig,
for example:
“[a] whole day on clinical research [was set up] last
year [. . .]. [T]he theme [was the idea of being a guinea
pig in research] and we [. . .] had patients [. . .] and
researchers [discuss on the matter]. [. . .] we put a lot
of literature out in the waiting room, which stimulate
[d] conversation [. . .and] the patients [had the
opportunity to] exchange a lot [among] themselves.
Are you on this study? Are you on that study? And so,
[. . .it encouraged] a culture of research.” (Interviewee 1)
Informed consent is a continuous process
This is especially true in non-therapeutic research where
the primary goal is not to provide clinically relevant
results that can benefit the individual. Many respondents
viewed the process of informed consent as an interactive
flow of ideas. There were indications regarding what in-
formation to provide, how to inform the patient, and
when to obtain his or her consent.
When obtaining permission from patients, respon-
dents highlighted the need for a thorough explanation of
the research process, fully disclosing what will happen.
“I explain everything from A to Z [to] the patient. And
then I introduce the study coordinator who then goes
through the, kind of walks it through on a, the logistics
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them a consent form. And I tell them they must ask
me two or three questions at least.” (Interviewee 1)
Another respondent suggested avoiding a group set-
ting for recruitment in favour of individual contacts.
This approach sets the stage for individual autonomy by
adequately answering patients’ questions and providing
easy access to the study coordinator and/or the phys-
ician, which are important steps for continuous support.
Timing of the consent process is an equally important
issue. Decisions about accepting to participate should
not occur on the first day or immediately after receiving
all the information. Patients are encouraged to take the
information home with them, so that they can think it
through before making their decision to consent. Asking
questions is also strongly encouraged by the health pro-
fessionals, who should make themselves available for
questions, to ensure that the patient fully comprehends
the research and has no hesitations.
Mention was made of the importance of informational
tools for patients to guide the consent process. When
multiple languages are spoken in a particular population
(French and English in Quebec), such tools should be
available in these languages to promote and encourage
participation in research.
Family dynamics and social support
Respondents identified the need for patients to feel sup-
ported by their families, because of the varying emo-
tional needs and the anxiety associated with treatment,
especially when there is little hope for survival.
“The family is always important, [. . .] to be there for
the treatment because the treatment is very hard, it’s
very tough and they [really] need [. . .] support because
even if there is hope, the patient will go up and down
with depression, with a lot of things which are really
expected and they need support, but when it’s hopeless,
they really need to [. . .have parents and family
around as. . .companions. . .]” (Interviewee 5)
An issue that may arise in the familial context is en-
tanglement, meaning differing opinions between patients
and their families regarding participation in non-
therapeutic research. Respondents noted that families
sometimes adopt a protective approach. As a result,
there are times when involving the family is challenging
due to these differences in opinions and views, and when
patients may fear burdening their families at a sensitive
time. For example:
“He agreed to enter the study but you know, most of
the time, in this case and in all the other case[s], thepatient doesn’t want to do something that can give
more concern to his family.” (Interviewee 2)
Interestingly the outlook and opinions of the patient
with an advanced illness may also lead to a change in pri-
orities, and as a result influence willingness to participate.
Therefore, conferring with families during the process is
important, as they can provide a support system for the
patient throughout the duration of the study.Psychosocial issues
The lowered expectation of survival faced by these
patients can create considerable psychological stress.
Respondents noted that the patients are emotionally la-
bile at the time of recruitment. These include: ups and
downs, anxiety, fear, overwhelmed (they need down time
or time to let their emotions subside), and reassurance.
Health professionals can make important contributions
by supporting and sharing information and insights
about the research with patients. Specifically, sitting with
the patient and the family to discuss the research proto-
col is likely to provide a better awareness of the difficul-
ties and hopes of the patients and their families.
“It’s [. . .a] totally different approach. Here we should
sit with the patient and with the family and we should
really be very comprehensive because [he] is hopeless
and [. . .] has a lot of things to face, he is facing a very
bad disease, he is going through treatments and he
doesn’t have hope so he is facing death and this is
really something big to deal with, and it depends on
the patient.” (Interviewee 5)
Respondents suggested that another positive commu-
nication resource that facilitates a more positive experi-
ence is to provide patients with true stories from other
patients. By listening to other patients, this reassures
them that they are not the first ones to participate in
such research.III. Health professional issues
A final theme emerging from the interviews are the
facilitators and barriers with respect to members of the
health professional team (Table 1). Many respondents
expressed concerns about the difficulties of carrying out
non-therapeutic research.Doctor-patient relationship
In order to foster a feeling of trust, respondents high-
lighted the importance of the doctor-patient relation-
ship. This relationship should be a transparent one,
where communication is valued and encouraged.
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know that our goal is to make everybody
comfortable and to give support in all of this.”
(Interviewee 3)
Moreover, the physician who cares for the patient may
also play the role of gate keeper to research participation
or may add pressure on the patient. For example, a
physician may feel that a patient has suffered enough
and for this reason denies researchers access to eligible
participants. In order to protect the patient, physicians
may perceive him or her as being unwilling to partici-
pate and make this decision for him or her.
“if this patient is not appropriate in a sense that she
suffered a lot, [. . .] leave her alone, I’m pretty sure
that I will have another case for my research [. . .]”
(Interviewee 5)
As a result, physicians sometimes partake in recruit-
ment for a research project only if they believe in its po-
tential to be beneficial. In some cases, the physician may
subconsciously communicate disinterest and hesitations
to the patient, thereby setting different priorities in the
recruitment process.
“I think that we should not force physicians to
participate in the project; they have to believe in those
projects.” (Interviewee 6)
Distinction between care and research
In some cases, the issue is that patients may think that
participation in research may have a therapeutic value
or provide another chance for survival. This is particu-
larly difficult when the patient has trust and confidence
in the physician. On the one hand, the patient may feel
reassured that the physician is involved, which may en-
courage participation. On the other hand, it may result
in the patient participating because he or she thinks
that since the physician suggested it, it must be appro-
priate (the patient is being influenced by the association
made between the physician and good, so it is not ne-
cessarily a voluntary decision, but one that has been
indirectly influenced by the physician – therapeutic
misconception).
“Usually that’s the way it is, but they don’t have any
idea about what the research is and you know that
when a physician [proposes something], it’s really
different from a nurse talking about research because
usually the patients have confidence in their physician
so they say, okay, if my oncologist is proposing the
protocol, it means that this is good for me.”
(Interviewee 5)Teamwork
Cohesive study teams and teamwork between physicians,
researchers and the research nurses were perceived as
facilitators when conducting non-therapeutic research.
Communication should be transparent and a lack of
communication makes it more difficult and stressful on
the patient and can cause anxiety.
“The physicians [. . .] evaluate the protocol first and
then they discuss [. . .] it in a team meeting and after
that [. . .] they kind of select the protocols that they
want to implement on [. . .their] side or don’t want to
implement and only after that will we start
everything.” (Interviewee 4)
It is felt that communication will be helped somewhat
by involving the nurse or study coordinator, because
they can play a very important role in promoting the
quality of the information.
“usually we like that somebody [. . .other] than the
investigator or the physician ask for the consent
[. . .from] the patient. I think it’s the ideal solution
when a research nurse or someone who is [. . .] very
aware of the project [. . .and] know[s] the project very
well, and then explains that they should take the time
needed to answer the questions and so on, but I think
[. . .] that if not, the physician can also, the treating
physician can ask for the consent. I don’t think it
creates a problem.” (Interviewee 6)
An important barrier to this recruitment process, how-
ever, are time constraints faced by clinicians who are
balancing clinical and research roles in a busy clinical
environment. Clinicians generally do not have the time
to fully explain a project and provide information about
the research.
“They’re simply very busy and just don’t have time to
think about it.” (Interviewee 7)
Finally, lack of awareness on the part of the clinicians
about the research project can lead to the obstruction of
research.
“My experience is that the greatest obstruction to
clinical research is not the patient, it is the other
physician. . .you have to get other physicians on board”
(Interviewee 7)
To foster commitment among clinicians, there is need
to integrate research and clinical work. Within such a
model, a mission statement (patient-centered care gener-
ating new knowledge) and standard operating procedures
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appropriately. In order to help with recruitment, it is
useful to build physician awareness and enthusiasm
about the research, and to encourage their voluntary
participation in it.
“it’s really important that [physicians] want to get
involved in the study because it will require time, it
will require energy, so that’s why it’s very important
that it’s on a voluntary basis.” (Interviewee 2)
Conflict of interest
Some respondents mentioned that conflicts of interest
may exist specifically at the time the clinicians recruit
patients to the research project because they have a
therapeutic relationship. Several respondents discussed
ways to address this concern. One suggested that it is es-
sential for physicians to go through the Informed Con-
sent Form with patients, highlighting that there will be
no direct therapeutic benefit for the patient, and this
may influence the patient’s decision to participate or not.
“We clearly say in [the] consent forms and verbally,
[that] we do not expect any clinical benefit [. . .for]
you. Patients still hold that hope. It’s human nature.”
(Interviewee 1)
Another respondent suggested ways to address this
issue. One approach that was recommended is for the
clinician-researcher to avoid direct recruiting contact.
Another approach is for a neutral party to seek the
patient’s consent. This position promotes the research
nurse who can make an important contribution and help
address the conflicts of interest because they do not use
this information for their own gain. Research nurses are
well positioned to obtain the patient’s consent because
they are aware and well-informed about the project, and
can provide the patient with answers to their questions
and the time needed to deliberate participation.
“Usually we like that somebody else [other] than the
investigator or the physician ask for the consent
[. . .from] the patient.” (Interviewee 6)
Although research nurses play a very important role, it
was also acknowledged that if the treating physician does
not have access to a research nurse, he or she can also
be an option for obtaining the consent.
Education and training
The importance of education and training was men-
tioned several times. It was stated that there appears
to be a lack of physicians with training in research and
research ethics. It was felt that training should occurwithin the medical school program and more should be
done to increase the number of physicians with such
training. Also, it was recognized that one important bar-
rier is that physicians typically appear to favour working
with patients in a clinical or hospital setting over getting
involved in research.
“Most physicians, when they choose [. . .] medicine as a
profession, they choose medicine to see patients, to
provide care, [and] not to do research. So it’s really a
minority of individuals who are really interested in
[. . .] research.” (Interviewee 6)
In addition to these skills, training should be compli-
mented by ongoing reminders about current research
projects and provided to physicians, who are normally
busy with their own practices and might not keep track
of research opportunities for their patients. Furthermore,
it is important for researchers and physicians to know
what they are looking for in the study so that they can
effectively answer the patient’s questions.
Research ethics boards (REB)
There were comments about the variability in how REBs
assess non-therapeutic research with some REBs more
open to the idea of such research.
“There are interests for [. . .] having non-therapeutical
protocols out there. I guess some [REBs] might be more
open to the option than others.” (Interviewee 4)
Several respondents indicated that research ethics
boards are necessary for the general oversight of non-
therapeutic research.
“if there is an increased risk, I think that usually the
Ethic[s] Committee has to evaluate whether the risk is
too important and usually you would not be allowed
to start a project that has too high a risk for the
patients” (Interviewee 6)
Funds
This type of recruitment is time consuming and requires
a team (e.g. physicians, researchers, research nurse) and
resources (e.g. work space) to enable a smooth and suc-
cessful process. For this reason, budgets are an issue.
“sometimes also you need more people to work but you
don’t have space. And the budget is not good enough.”
(Interviewee 3)
Discussion
Although international guidelines address the re-
cruitment of patients into non-therapeutic research,
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are still at play [20]. Our findings suggest that challenges
in conducting non-therapeutic research are distinct from
those derived from research for therapeutic reasons and
reveal a number of ethical and practical challenges for
physicians and researchers alike. We characterized these
challenges as barriers and facilitators surrounding ethical
considerations, patient-centered care, and the profes-
sional relationship.
Our analysis identified that respondents seemed well
informed of the ethical principles of autonomy, benefi-
cence, the need to respect the patient and to put his or
her interests ahead of those of society. Risk of discrimin-
ation by employers and insurance companies was
expressed as well as concerns about the confidentiality
of the research results, and the impact of such informa-
tion on patients’ families. These findings are supported
by the literature surrounding issues of confidentiality
and discrimination [7,8]. Furthermore, due to the close
ties between ethics and clinical practice, physicians
should only partake in recruitment on a voluntary basis;
otherwise they may inadvertently convey their disinterest
to the potential participants, and negatively impact par-
ticipation. Finally, there were a number of respondents
who indicated that giving back to society and the desire
to help future generations, even if there are no specific
benefits for the patients themselves, were important
moral values for patients who affirmed their willingness
to participate.
In addition to ethical challenges, there were spe-
cific facilitators and barriers for recruiting patients to
non-therapeutic research. Facilitators were most often
associated with patient-centered issues enhancing com-
munication, while barriers to non-therapeutic research
were most often professionally based.
Families were identified as a positive factor and a
source of information throughout the process. The fam-
ily unit was perceived as an essential source of support
for the patient, along with real feedback and true stories
from individuals who have already gone through similar
experiences. They provide the patient with a sense of re-
assurance, thus fostering integration and improving par-
ticipation in such studies.
Another facilitator for recruitment is the role played
by research nurses. Notably, they are seen as a source of
support or as an “extra pair of hands” involved in the
care of the patient. Respondents identified them as a
more neutral party than researchers, having less of a
vested interest in the research, and making them an
ideal candidate for obtaining participants’ consent.
Nonetheless, it is important to note that nurses, like
physician-researchers, may be susceptible to conflicts of
interest and steps should be taken to ensure that any
such conflict is limited and disclosed to potentialparticipants [23]. Respondents also supported the idea
that the informed consent process should be active, vol-
untary and that it is important to take the time to an-
swer questions, transmit the information, and be
available for the patient. These findings affirm the issues
of time constraints and information transmission
explored in the literature [7].
The team approach can enhance communication to
patients. The image of a team, working together
throughout every step, is favoured for non-therapeutic
research. Respondents indicated that this communica-
tion should be transparent among all parties, resulting in
patients who are well informed and supported. These
findings resonate with the literature on doctor-patient
communication [24]. Another facilitator is the import-
ance of knowledge translation and educating the public
about the research. Greater awareness among the
patients of the different types of research going on could
help to reduce any negative ideas and misconceptions
that may exist (i.e. the guinea pig perception) and be an
effective approach to improving recruitment.
Our findings also indicate that respondents acknow-
ledge the importance of the doctor-patient relationship
in promoting trust [25]. However, there are several chal-
lenges associated with integrating the clinician/re-
searcher role into research. Respondents suggested that
a therapeutic misconception may occur because the trust
the patient has toward the physician can have an influ-
ence. If the physician suggests it, then it must be the
right option. This challenge, for example, stems from
the need to take the time to fully discuss the research
and the recognised lack of time to do so, due to busy
schedules. In order to promote participation in research,
physicians (families, nurses, and REBs too) should try
not to intervene and influence the patient’s decision.
Furthermore, the lack of awareness of research by
other physicians was seen as the “greatest obstruction”
to research recruitment. A solution proposed for rem-
edying this barrier is to try to get physicians on board
with the research that is taking place. Such a strategy
may help enhance recruitment and the advancement of
research.
Moreover, there appears to be a generation gap among
physicians, with the younger ones having less of an
interest in and awareness of research; therefore, an effort
should be made to reverse this trend and further educate
physicians. Respondents noted that it is useful to foster a
commitment to training programs that expose medical
students to research and encourage an interest in it. The
current study sheds light on the importance of research
ethics in the medical curriculum. Although the ideal
time to introduce research ethics into medical training
can be a source of debate, it is generally introduced dur-
ing the undergraduate curriculum and then further
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training [26]. This training is also encouraged to be a
continuous process and the teaching to promote active
participation in the learning [26]. Finally, despite the
undergraduate medical curricula workload, integrating
research ethics can be seen as necessary in order to train
physicians who are more sensitive to and conscious of
the ethical aspects that exist in their daily practice [26].
A final barrier to recruitment is the need to address the
vulnerability of the patient and to be sensitive to a variety
of emotional responses throughout the recruitment
process such as depression, distress, and reassurance.
Existing research supports our finding that patients ex-
perience a range of emotional readiness [27]. Given the
important role of families, it will be important to incorp-
orate them in the process as much as possible [28].
Based on our findings, we offer several points to con-
sider in order to overcome barriers to recruitment for
non-therapeutic research (see Figure 1). These examples
are divided into patient-centered issues and health pro-
fessional issues influencing non-therapeutic research.
Each of the divisions outlines the issues at hand and
provides strategies for dealing with and achieving a better
understanding of the challenges. Promoting communica-
tion and autonomy and fostering familial support are im-
portant elements for overcoming patient-centered issues,
while facilitating the doctor-patient relationship and team-
work and implementing educational programs are seen
as key factors for dealing with health professional issues.
This study has limitations. First, it is an exploratory
study focused on a small research community. It was
not large enough to allow saturation of subtle differences
between sub-groups (e.g. oncologists, geneticists, clini-
cians not involved in research). For this reason, the
results do not represent the views of a more general
community of researchers. Also, the use of volunteer
health professional respondents may have resulted in an
overrepresentation of those involved in clinical research.
Further research with clinicians who are not actually
involved in research is needed, to assess their views on
the recruitment of their patients for non-therapeutic
research. Finally, it is possible that additional inter-
views with researchers and/or clinicians could generate
other themes that were not identified in this project.
Nevertheless, this study fills an important gap in the
literature by addressing the barriers and facilitators to
non-therapeutic research under three prominent themes:
ethical considerations, patient-centered issues, and health
professional issues.Conclusions
In conclusion, while patients are truly vulnerable, we
take the view that non-therapeutic research is ethicallyjustified primarily because of the benefit for society.
If we did not ask seriously ill patients to participate,
then medical science could not advance, at least in
those fields where the only possible avenue for re-
search (at least at this time) requires the use of
diseased tissue. This is not to say that just any re-
search can proceed when the harms outweigh the
benefits; the risks must be justifiable. Therefore, the
protection of research participants from excessive
harms is very important. This is a responsibility of
both the researchers and the REBs that oversee the
research (including protocols and informed consent
forms). Based on anecdotal evidence from our re-
search team, it appears that for this research some
REBs are hesitant to approve a study where there is
greater than minimal risk with no direct benefit;
however, the autonomy of the patient/participant
combined with mechanisms to ensure that they are
appropriately informed of the risks can ensure that
participation is fully voluntary and informed. Furthermore,
this type of research is supported in Canada by
article 11.4 of the Tri-Council Policy Statement:
Ethical Conduct for Research Involving Humans
(TCPS 2), which sees it as justified when researchers
and REBs ensure that the potential risk is appropriately
minimized and is outweighed by the potential bene-
fits. The TCPS 2 goes on to state that ethical princi-
ples of respect for persons and concern for welfare
guide this research, as well as any research with
direct benefit [29]. Finally, it has recently been advo-
cated by ethics commentators that an obligation
to participate in biomedical research should exist
because research produces a public good that is ac-
cessible to everyone [30].
This exploratory study reveals the challenges of wrest-
ling with the recruitment of patients to non-therapeutic
research. As the science continues to evolve, closer col-
laboration with clinicians will be required in order to en-
sure respect of patients and more social and emotional
support for them throughout the research process and
the course of their disease.
Due to the important frontline role that researcher-
clinicians play, it is imperative to introduce: a better
understanding of the challenges researchers/clinicians
face when recruiting patients for non-therapeutic re-
search; help improve effective communication among all
members of the team, as well as with patients and their
families (effective communication training programs/
workshops); and facilitate better access to training pro-
grams about the value of non-therapeutic research. An
important next step is to initiate research exploring the
views of participants regarding non-therapeutic research,
as well as the views of clinicians not involved in non-
therapeutic research.
Kleiderman et al. BMC Medical Ethics 2012, 13:33 Page 12 of 12
http://www.biomedcentral.com/1472-6939/13/33Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
EK participated in the development of a conceptual framework, the analysis
of data, and the drafting of the manuscript. DA conceived the study,
participated in the design of the study, the development of a conceptual
framework, the collection and analysis of data, and the drafting of the
manuscript. LB was involved in the design of the study, the collection of
data, and the revision of the manuscript. ZD and CR participated in the
coordination of the study and provided support and critical analysis of the
manuscript. BMK provided support and critical analysis of the manuscript. EK
wrote the first draft of the manuscript; DA and LB commented on the drafts.
All authors read and approved the final manuscript.
Acknowledgements
We would like to thank the health professionals (research and hospital staff)
who took part in the interviews. This project was funded by the ‘Fonds de la
recherche en santé Québec’ (FRSQ) through the Pfizer-FRSQ Innovation Fund
(project titled: “Prospective Study to Identify Molecular Mechanisms of
Clinical Resistance to Standard First-Line Therapy in Patients with Metastatic
Colorectoral Cancer” – Grant #16759) and the ‘Réseau de Médecine
Génétique Appliquée’ (RMGA). We would also like to thank the Québec –
Clinical Research Organization in Cancer (Q-CROC) for their help in the
recruitment of participants to this study.
Author details
1Centre of Genomics and Policy, Faculty of Medicine, Dept of Human
Genetics, McGill University, 740 Dr. Penfield Avenue, 5th Floor, Suite 5200,
Montreal, (QC) H3A 1A4, Canada. 2Québec-Clinical Research Organization in
Cancer (Q-CROC), Jewish General Hospital, 3755 Côte Ste-Catherine Road,
Suite E-445, Montreal, (QC) H3T 1E2, Canada.
Received: 17 July 2012 Accepted: 29 November 2012
Published: 5 December 2012
References
1. Wistuba II, Gelovani JG, Jacoby JJ, Davis SE, Herbst RS: Methodological and
practical challenges for personalized cancer therapies. Nat Rev Clin Oncol
2011, 8(3):135–141.
2. Institute for Clinical Systems Improvement (ICSI): Health Care Guideline.
Palliative Care, 4th edn; 2011:62.
3. Casarett DJ, Karlawish JHT: Are Special Ethical Guidelines Needed For
Palliative Care Research? Journal of Pain and Symptom Management 2000,
20(2):130–139.
4. Mount BM, Cohen R, MacDonald N, Bruera E, Dudgeon DJ: Ethical issues in
palliative care research revisited. Palliative Medicine 1995, 9(2):165–166.
5. Mahowald MB, Aspinwall T, Scheuerle A: Genetics in the clinic: clinical,
ethical and social implications for primary care. 2001, 67.
6. Jubb A: Palliative care research: trading ethics for an evidence base.
Journal of medical ethics 2002, 28(6):342.
7. Otlowski M, Taylor S, Bombard Y: Genetic Discrimination: international
Perspectives. Annual Review of Genomics and Human Genetics 2012,
13(1):6.1–6.22.
8. Nedelcu R, Blazer KR, Schwerin BU, Gambol P, Mantha P, Uman GC, Weitzel
JN: Genetic discrimination: the clinician perspective. Clinical Genetics 2004,
66(4):311–317.
9. Hall MA, McEwen JE, Barton JC, Walker AP, Howe EG, Reiss JA, Power TE,
Ellis SD, Tucker DC, Harrison BW, et al: Concerns in a primary care
population about genetic discrimination by insurers. Genet Med 2005,
7(5):311–316.
10. Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N,
Matthews E: To tell or not to tell: barriers and facilitators in family
communication about genetic risk. Clinical Genetics 2003, 64(4):317–326.
11. Wilson BJ, Forrest K, van Teijlingen ER, McKee L, Haites N, Matthews E,
Simpson SA: Family communication about genetic risk: the little that is
known. Public Health Genomics 2004, 7(1):15–24.
12. Kottow M: Ethical quandaries posing as conflicts of interest. Journal of
medical ethics 2010, 36(6):328–332.
13. Hardwig J: What About the Family? Hastings Center Report 1990,
20(2):5–10.14. Nelson JL: Taking Families Seriously. Hastings Center Report 1992,
22(4):6–12.
15. Pollak KI, Arnold RM, Jeffreys AS, Alexander SC, Olsen MK, Abernethy AP,
Sugg Skinner C, Rodriguez KL, Tulsky JA: Oncologist communication about
emotion during visits with patients with advanced cancer. Journal of
Clinical Oncology 2007, 25(36):5748–5752.
16. Russell BJ, Ward AM: Deciding what information is necessary: do patients
with advanced cancer want to know all the details? Cancer Management
and Research 2011, 3:191.
17. Casarett D, Pickard A, Fishman JM, Alexander SC, Arnold RM, Pollak KI, Tulsky
JA: Can metaphors and analogies improve communication with seriously
ill patients? Journal of palliative medicine 2010, 13(3):255–260.
18. Montgomery C, Lydon A, Lloyd K: Psychological distress among cancer
patients and informed consent. Journal of Psychosomatic Research 1999,
46(3):241–245.
19. Leydon GM, Boulton M, Moynihan C, Jones A, Mossman J, Boudioni M,
McPherson K: Cancer patients’ information needs and information
seeking behaviour: in depth interview study. BMJ 2000, 320(7239):909–913.
20. Roy Choudhury S, Knapp LA: A review of international and UK-based
ethical guidelines for researchers conducting nontherapeutic genetic
studies in developing countries. Eur J Hum Genet 2005, 14(1):9–16.
21. Cancer Staging Fact Sheet: http://www.cancer.gov/cancertopics/factsheet/
detection/staging.
22. Patton MQ: Qualitative Research and Evaluation Methods. 3rd edition.
Thousand Oaks, CA: Sage Publications, Inc.; 2002.
23. Raudonis BM: Ethical Considerations in Qualitative Research with Hospice
Patients. Qualitative Health Research 1992, 2(2):238–249.
24. Ong LML, de Haes JCJM, Hoos AM, Lammes FB: Doctor-patient
communication: A review of the literature. Social Science &amp; Medicine
1995, 40(7):903–918.
25. Libert Y, Reynaert C: Les enjeux de la communication médecin-patient et
l’importance des caractéristiques psychologiques du médecin. Psycho-
Oncologie 2009, 3(3):140–146.
26. Rameshkumar K: Ethics in medical curriculum; Ethics by the teachers for
students and society. Indian Journal of Urology 2009, 25(3):337–339.
27. Koropchak CM, Pollak KI, Arnold RM, Alexander SC, Skinner CS, Olsen MK,
Jeffreys AS, Rodriguez KL, Abernethy AP, Tulsky JA: Studying
communication in oncologist-patient encounters: The SCOPE Trial.
Palliative Medicine 2006, 20(8):813–819.
28. Delvaux N, Merckaert I, Marchal S, Libert Y, Conradt S, Boniver J, Etienne A-M,
Fontaine O, Janne P, Klastersky J, et al: Physicians’ communication with a
cancer patient and a relative. Cancer 2005, 103(11):2397–2411.
29. Canadian Institutes of Health Research: Tri-council Policy Statement: Ethical
Conduct for Research Involving Humans, 2nd edn.: Interagency Secretariat on
Research Ethics; 2010.
30. Schaefer GO, Emanuel EJ, Wertheimer A: The obligation to participate in
biomedical research. JAMA: The Journal of the American Medical Association
2009, 302(1):67–72.
doi:10.1186/1472-6939-13-33
Cite this article as: Kleiderman et al.: Recruiting Terminally Ill Patients
into Non-Therapeutic Oncology Studies: views of Health Professionals.
BMC Medical Ethics 2012 13:33.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
